Answers are grounded in this paper and cite their sources.
Clear cell sarcoma is a rare tumor with a poor prognosis. The therapeutic approach in the metastatic disease stage is controversial: to the authors' knowledge the use of concurrent chemoimmunotherapy has not been previously reported. We present a case of a 57-year-old male with metastatic clear cell sarcoma treated simultaneously with subcutaneous interferon-a 2b and six courses of chemotherapy according to the CyVEDIC regimen. Disease stabilization lasting 17 months was achieved.
No takes yet. Share an insight, caveat, or question.
Lauro et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: